Product Information
DEXMETHYLPHENIDATE ER 20 MG CP is a generic product labeled by Par Health USA, LLC, priced at $1.6924 per EA under NDC 49884024801. Its NADAC has been published 479 times since Aug 2, 2017.
FDA first approved this application on Nov 30, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Par Health USA, LLCNDC
49884024801
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202842FDA Approved
11/30/2016
TE Code
AB
On Market Since
1/5/2017
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 20 MG CP has been published 479 times since Aug 2, 2017, and over the history we have for it it has declined 69.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6924 per EA |
|---|---|
| All-time high | $5.9234 (Sep 13, 2017) |
| All-time low | $0.8396 (Jul 17, 2024) |
| 52-week high | $2.0379 |
| 52-week low | $1.6115 |
| Median price | $1.9106 |
| Average price | $2.6714 |
| Largest weekly change | +70.2% (Aug 21, 2024) |
| Weeks tracked | 479 |
| Tracking since | Aug 2, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Par Health USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 20 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 20 MG CP, manufactured by Par Health USA, LLC, is $1.6924 per EA (NDC 49884024801), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE ER 20 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 20 MG CP has declined 69.9%. It has been tracked across 479 weekly CMS publications since Aug 2, 2017.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 20 MG CP?
Since Aug 2, 2017, the NADAC for DEXMETHYLPHENIDATE ER 20 MG CP has ranged from a low of $0.8396 (Jul 17, 2024) to a high of $5.9234 (Sep 13, 2017), with a median of $1.9106 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 20 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE ER 20 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXMETHYLPHENIDATE ER 20 MG CP?
DEXMETHYLPHENIDATE ER 20 MG CP (NDC 49884024801) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.